What does aclinic do?

aclinic is a specialist medical practice in Oostkamp. Private Limited, started on 4 April 2014, 1 establishment.

What is the address of aclinic?

The registered office of aclinic is located at Gruuthuselaan 7, 8020 Oostkamp.

Is aclinic still active?

Yes. According to the CBE (31 October 2026) aclinic is active, legal situation “Normale toestand”, started on 4 April 2014.

Is aclinic registered on Peppol?

Yes, aclinic is registered on the Peppol network with ID 0208:0550391064.

What is the enterprise number of aclinic?

The enterprise number of aclinic is BE0550391064.

When was aclinic founded?

aclinic was founded on 4 April 2014.

Who are the directors of aclinic?

According to the 2025 annual accounts, the directors of aclinic are: MARC VANDEVOORT, PIETER VERMEULEN, STEFAAN VAN DEN BERGE, GERD FABRE.

Is aclinic a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 April 2014; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did aclinic make in 2025?

aclinic posted a profit after taxes of € 324,489 in financial year 2025.

What is the revenue of aclinic?

As a small company, aclinic is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,266,389.

How much does an employee at aclinic earn?

The average wage cost per full-time employee at aclinic was € 69,300 in 2025: staff costs of € 249,542 for 3.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does aclinic have?

According to the 2025 annual accounts, aclinic has 3.6 full-time equivalents (FTE).

Does aclinic have a website?

Yes, aclinic has a website at aclinic.be.

aclinic (Private Limited) - Oostkamp - BE0550391064

Dossier aclinic, printed on 31 October 2026 from databakkes.be/en/0550391064/aclinic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

aclinic from Oostkamp, company number BE0550391064, closed financial year 2025 with a result of € 324,489 after tax. For that financial year aclinic recorded a gross margin of € 2.3 million and equity of € 658,730. Compared with financial year 2024, the result moved from € 245,511 to € 324,489. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.

What it is worth Growing

€ 658,730

▲ 97% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 324,489

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 340,741

▲ 186% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 657,730.

People and assets in 2025

Full-time equivalents

3.6

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 249,542

▲ 27% vs 2024

€ 69,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4 million

▲ 32% vs 2024

Of which on lease € 4 million.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 3.6 million

▲ 9% vs 2024

€ 206,855 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 151,995

▼ 79% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 81,748

▲ € 75,755 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 165,389 Gross margin 2022: € 165,389 First fiscal year in the series	€ 343,077 Gross margin 2023: € 343,077 ▲ 107% vs 2022 (€ 165,389) Favourable step	€ 3,689,256 Gross margin 2024: € 3,689,256 ▲ € 3.3 million vs 2023 (€ 343,077) Favourable step	€ 2,266,389 Gross margin 2025: € 2,266,389 ▼ 39% vs 2024 (€ 3,689,256) Unfavourable step	▼ 39%
Profit after taxes	€ 5,111 Profit after taxes 2022: € 5,111 First fiscal year in the series	€ 24,623 Profit after taxes 2023: € 24,623 ▲ € 19,512 vs 2022 (€ 5,111) Favourable step	€ 245,511 Profit after taxes 2024: € 245,511 ▲ € 220,888 vs 2023 (€ 24,623) Favourable step	€ 324,489 Profit after taxes 2025: € 324,489 ▲ 32% vs 2024 (€ 245,511) Favourable step	▲ 32%
Equity	€ 64,107 Equity 2022: € 64,107 First fiscal year in the series	€ 88,730 Equity 2023: € 88,730 ▲ 38% vs 2022 (€ 64,107) Favourable step	€ 334,241 Equity 2024: € 334,241 ▲ 277% vs 2023 (€ 88,730) Favourable step	€ 658,730 Equity 2025: € 658,730 ▲ 97% vs 2024 (€ 334,241) Favourable step	▲ 97%
Total debts	€ 1,246,024 Total debts 2022: € 1,246,024 First fiscal year in the series	€ 2,473,608 Total debts 2023: € 2,473,608 ▲ 99% vs 2022 (€ 1,246,024) Unfavourable step	€ 4,364,170 Total debts 2024: € 4,364,170 ▲ 76% vs 2023 (€ 2,473,608) Unfavourable step	€ 4,198,694 Total debts 2025: € 4,198,694 ▼ 4% vs 2024 (€ 4,364,170) Favourable step	▼ 4%
Cash	€ 30,589 Cash 2022: € 30,589 First fiscal year in the series	€ 19,036 Cash 2023: € 19,036 ▼ 38% vs 2022 (€ 30,589) Unfavourable step	€ 119,124 Cash 2024: € 119,124 ▲ € 100,087 vs 2023 (€ 19,036) Favourable step	€ 340,741 Cash 2025: € 340,741 ▲ 186% vs 2024 (€ 119,124) Favourable step	▲ 186%
Land & buildings	€ 1,220,715 Land & buildings 2022: € 1,220,715 First fiscal year in the series	€ 2,476,143 Land & buildings 2023: € 2,476,143 ▲ 103% vs 2022 (€ 1,220,715) Unchanged	€ 979,647 Land & buildings 2024: € 979,647 ▼ 60% vs 2023 (€ 2,476,143) Unchanged	€ 129,231 Land & buildings 2025: € 129,231 ▼ 87% vs 2024 (€ 979,647) Unchanged	▼ 87%
Retained profit	€ 63,107 Retained profit 2022: € 63,107 First fiscal year in the series	€ 87,730 Retained profit 2023: € 87,730 ▲ 39% vs 2022 (€ 63,107) Favourable step	€ 333,241 Retained profit 2024: € 333,241 ▲ 280% vs 2023 (€ 87,730) Favourable step	€ 657,730 Retained profit 2025: € 657,730 ▲ 97% vs 2024 (€ 333,241) Favourable step	▲ 97%
Bank debt	€ 873,406 Bank debt 2022: € 873,406 First fiscal year in the series	€ 2,188,436 Bank debt 2023: € 2,188,436 ▲ 151% vs 2022 (€ 873,406) Unfavourable step	€ 3,305,062 Bank debt 2024: € 3,305,062 ▲ 51% vs 2023 (€ 2,188,436) Unfavourable step	€ 3,586,197 Bank debt 2025: € 3,586,197 ▲ 9% vs 2024 (€ 3,305,062) Unfavourable step	▲ 9%
Balance sheet total	€ 1,310,132 Balance sheet total 2022: € 1,310,132 First fiscal year in the series	€ 2,562,339 Balance sheet total 2023: € 2,562,339 ▲ 96% vs 2022 (€ 1,310,132) Unchanged	€ 4,698,412 Balance sheet total 2024: € 4,698,412 ▲ 83% vs 2023 (€ 2,562,339) Unchanged	€ 4,857,424 Balance sheet total 2025: € 4,857,424 ▲ 3% vs 2024 (€ 4,698,412) Unchanged	▲ 3%
Employees (FTE)	-	-	2.8 Employees (FTE) 2024: 2.8 First fiscal year in the series	3.6 Employees (FTE) 2025: 3.6 ▲ 0.8 vs 2024 (2.8) Unchanged	▲ 0.8

Key figures of aclinic, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to aclinic?

What happened at aclinic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 20, 2026 New annual accounts for financial year 2025: profit of € 324,489 (▲ 32% vs 2024). Source: NBB ↗
Jan 13, 2025 New establishment in Oostkamp. KBO
Apr 4, 2014 Start of the company according to the CBE. KBO

In short

From € 5,111 profit in 2022 to € 324,489 profit in 2025.

Paid € 79,899 in corporate taxes since 2022.

Best year ever: 2025, with € 324,489 profit.

On average € 629,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MARC VANDEVOORT PIETER VERMEULEN STEFAAN VAN DEN BERGE GERD FABRE

DOKTER PIETER VERMEULEN, PLASTISCH CHIRURG

aclinic

Behind aclinic are MARC VANDEVOORT, PIETER VERMEULEN, STEFAAN VAN DEN BERGE and GERD FABRE. PIETER VERMEULEN is also behind DOKTER PIETER VERMEULEN, PLASTISCH CHIRURG.

Directors

According to the 2025 annual accounts

MARC VANDEVOORT

Director

PIETER VERMEULEN

Director

Also active at: DOKTER PIETER VERMEULEN, PLASTISCH CHIRURG

STEFAAN VAN DEN BERGE

Director

GERD FABRE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gruuthuselaan 7

8020 Oostkamp

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS aclinic.be

Canonical: https://www.aclinic.be/nl

Technologies

Cookie ConsentCraft CMSGoogle Tag ManagerLightboxNginxPHPlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Languages EN, NL

Features

Newsletter Ads

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number: 0550.391.064
VAT number: BE 0550.391.064
Registered office: Gruuthuselaan 7, 8020 Oostkamp
Names & denominations: aclinic
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 April 2014
Peppol: Active · Active since 1 Jan 2001
Contact: aclinic.be +32 (0)50 97 79 30
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

aclinic

Financials

What happened to aclinic?

Management

Directors

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions